单词agranulocytosis
n.: 【医】粒性白血球缺乏症
网络: 粒细胞缺乏症；粒性白细胞缺乏症；粒细胞减少症
【医学】粒性白血球缺乏症
恶性中性白细胞减少
粒性白细胞缺乏症
颗粒细胞乏症
粒细胞减少
粒细胞缺乏性脓毒症
粒细胞缺乏症
The literature concerning clozapine-induced agranulocytosis and its treatment with growth factors consists of only a few case reports.
文献中关于氯氮平引起的粒细胞缺乏症及其与生长因子治疗方法包括只有少数病例报告。
Objective To investigate the features and treatment of nosocomial infection in the agranulocytosis of patients with hematological diseases.
目的：探讨血液病粒细胞缺乏症患者发生医院感染的特点及防治措施。
Agranulocytosis and hepatotoxic reactions are rare but severe side-effects of neuroleptic treatment.
粒细胞缺乏症和肝脏的反应是罕见但严重的副作用抗精神病药物治疗。
The present paper addresses the following questions: what is the potential background of drug-induced agranulocytosis?
本文件讨论了下列问题：什么是潜在的背景药物引起粒细胞缺乏症？
In four patients, a woman aged 85 and three men aged 33, 42 and 70 years, clozapine-induced agranulocytosis was diagnosed.
在4名患者，女，年龄85岁及33,42和70年来，氯氮平引起的粒细胞缺乏症三名男子被诊断。
The response rate in febrile agranulocytosis patients was 51. 9%.
粒细胞缺乏合并感染患者中的有效率为51.
The infection rate was 69. 39% and 18. 64% in agranulocytosis and non-agranulocytosis patients respectively (P05).
粒细胞缺乏与无粒细胞缺乏者感染率分别是69.39%和18.64%，两者差异有显著性（P0.05）。
the susceptible factors to fungal infection are agranulocytosis and administration of broad-spectral antibiotics in acute leukemia patients;
使用广谱抗生素、中性粒细胞缺乏是急性白血病患者合并真菌感染的易感因素；
Clinical Analysis of Characteristics and Treatment of Non-chemotherapeutic induced Agranulocytosis
非化疗药物致粒细胞缺乏症的临床特点及治疗分析
Severe agranulocytosis and acute hepatic injury due to propylthiouracil
丙硫氧嘧啶致严重粒细胞缺乏及急性肝损害